Royal Caribbean Cruises Ltd (RCL) Stock Price Today
Aura AI Summary
Key Stats
- $75.09BMARKET_CAP
- -VOLUME
- Consumer CyclicalSECTOR
- $365.84FIFTY_TWO_WEEK_HIGH
- $246.71FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $96.37BENTERPRISE_VALUE
- 1.69%DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track Royal Caribbean Cruises Ltd (RCL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Royal Caribbean Cruises Ltd has traded between a low of $246.71 and a high of $365.84, highlighting its annual price range. Buy and sell Royal Caribbean Cruises Ltd shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Royal Caribbean Cruises Ltd
Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Most Recent News
State Street Global Advisors increases stake in DCC plc to nearly 1.4% with recent share purchases.
State Street Global Advisors & Affiliates disclosed an increase in their holdings of DCC plc ordinary shares to 1,194,093 shares, representing approximately 1.398% of the company. The purchases occurred on July 3, 2026, at a price of €60.90 per share...

Global Family Office Summit in Lake Como spotlights AI, private markets, and global investment trends.
The 32nd Global Family Office Investment Summit in Lake Como gathered over 200 family office leaders, investors, and entrepreneurs from 27 countries to discuss emerging trends in AI, private equity, healthcare innovation, and global investment opport...

GuideAI appoints vascular expert Dr. Benenati after FDA clears its AI vascular triage software VAOT
GuideAI Health Corp. has appointed Dr. James F. Benenati, a leading interventional radiologist, to its Advisory Board following FDA 510(k) clearance of its AI software, VascularAssist Occlusion Triage (VAOT). VAOT is designed to help radiologists pri...
